Seer, Inc.
HealthcareNASDAQ:SEER · NASDAQ Global Select
+$0.02 today
Vol 0.10M · Avg 0.33M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-16.91%
Period High
$2.37
Period Low
$1.66
Latest
$1.72
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Kymera Therapeutics, Inc.
NASDAQ:KYMR
$7.09B
Pharvaris N.V.
NASDAQ:PHVS
$2.15B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
$1.57B
Nurix Therapeutics, Inc.
NASDAQ:NRIX
$1.47B
Monte Rosa Therapeutics, Inc.
NASDAQ:GLUE
$1.19B
ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
$856.09M
Cullinan Therapeutics, Inc.
NASDAQ:CGEM
$841.97M
Sana Biotechnology, Inc.
NASDAQ:SANA
$745.82M
C4 Therapeutics, Inc.
NASDAQ:CCCC
$323.03M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
$315.01M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
$245.42M
Shattuck Labs, Inc.
NASDAQ:STTK
$236.64M
Nkarta, Inc.
NASDAQ:NKTX
$204.62M
Quantum-Si incorporated
NASDAQ:QSI
$187.28M
Molecular Partners AG
NASDAQ:MOLN
$154.17M
AN2 Therapeutics, Inc.
NASDAQ:ANTX
$129.89M
PepGen Inc.
NASDAQ:PEPG
$101.68M
MediciNova, Inc.
NASDAQ:MNOV
$60.54M
Generation Bio Co.
GBIO
$35.98M
Anebulo Pharmaceuticals, Inc.
ANEB
$15.91M
HCW Biologics Inc.
HCWB
$2.67M
What is the latest SEER filing?
The latest filing shown is DEFA14A dated Jun 11, 2026.
How many recent filings does SEER have?
Intrinsic Alpha currently shows 20 recent filings for SEER.
Explore More
Continue the stock analysis
Jump to another research area for this company.